The US Food and Drug Administration (FDA) has selected Abeona Therapeutics’ ABO-503 gene therapy for X-linked retinoschisis ...

Pediatric progressive myopia is a growing global public health concern, linked to serious ocular complications including ...

Michaelides is professor at UCL Institute of Ophthalmology and Moorfields Eye Hospital, London.

The Polaris platform is the world’s first AI-supported and robotics-enabled surgical system developed specifically for ...

Fotis Topouzis, MD, PhD, is chair of the Department of Ophthalmology, Aristotle University of Thessaloniki, Greece, and current president of the European Glaucoma Society. He is principal investigator ...

The Eye Care Network caught up with Inder Paul Singh, MD, president of The Eye Centers of Racine and Kenosha in Wisconsin and founding medical advisor for Alchemy Vision, to learn more about the ...

The US Food and Drug Administration (FDA) has approved Celltrion’s aflibercept-boav (EYDENZELT) biosimilar referencing aflibercept (EYLEA) for the treatment of neovascular (wet) age-related macular ...

Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...

The AAOP's new training platform, developed with Alchemy Vision, enhances practice efficiency and patient care through video-driven education for ophthalmic technicians and clinical team members.

On Sunday, October 19, attendees can enjoy Universal Islands of Adventure from 5:00 p.m., and then from 8:00 to 11:30 p.m., AAO invites conference attendees to “unlimited access to the most amazing ...

REGENXBIO completed enrollment in its ATMOSPHERE and ASCENT trials that will be evaluating surabgene lomparvovec (sura-vec, ...